What is GALD?
- A rare disorder where the mother's immune system attacks the fetal liver.
- Leads to iron accumulation and liver tissue damage (Neonatal Hemochromatosis).
- Presents a high risk to the newborn's life without prenatal intervention.
Book GALD Management in Saudi Arabia | Lahalak Medical Platform
A specialized management program aimed at protecting the fetus from neonatal hemochromatosis by administering IVIG to at-risk mothers, ensuring a healthy birth and preventing severe liver complications in newborns.
Scientific name: Gestational Alloimmune Liver Disease (GALD) Management
Advanced preventive management involving high-dose intravenous immunoglobulin (IVIG) administration during pregnancy for mothers with a history of GALD to prevent fetal liver damage and neonatal hemochromatosis.
Service type
Preventive therapeutic program
Duration
2-4 hours
Fasting
Fasting is not required
Included Services
- High-risk pregnancy consultation
- IVIG administration
- Maternal and fetal vital signs monitoring
- Regular fetal monitoring
Medical Service Information
Importance of IVIG Treatment
- Reduces the transfer of harmful antibodies from mother to fetus.
- Prevents fetal liver failure and iron overload.
- Significantly increases the chances of delivering a healthy baby.
Target Groups
- Pregnant women with a prior history of a baby affected by GALD.
- Cases diagnosed with neonatal hemochromatosis in a previous pregnancy.
- Mothers referred from high-risk pregnancy clinics.
Conditions & Notices
- Prior history of GALD/Neonatal Hemochromatosis
- Approval from a feto-maternal specialist
- Pre-procedure laboratory screening
Medical services you might also like
